TLR3 and neoplasm: Since TLR3 along with its downstream signaling responses have anti-cancer properties including immune-mediated tumor growth suppression and a direct apoptotic effect on TLR3 expressing cancer cells [27–30], TLR3 is currently being investigated for therapeutic interventions in cancer treatment [21, 31].